These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35029867)

  • 1. Revascularization strategies in patients with diabetes and stable ischemic heart disease: a systematic review and meta-analysis of randomized trials.
    Noguchi M; Ueyama H; Fujisaki T; Takagi H; Kuno T
    J Cardiovasc Med (Hagerstown); 2022 Apr; 23(4):242-246. PubMed ID: 35029867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials.
    Kumar A; Doshi R; Khan SU; Shariff M; Baby J; Majmundar M; Kanaa'N A; Hedrick DP; Puri R; Reed G; Mehran R; Kapadia S; Khot UN; Kalra A
    Cardiovasc Revasc Med; 2022 Jul; 40():42-47. PubMed ID: 35210188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
    Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
    J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease.
    Bi L; Geng Y; Wang Y; Li S; Sun K; Guo Y; Zhang O; Zhang P
    BMC Cardiovasc Disord; 2024 Jul; 24(1):335. PubMed ID: 38961354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
    Bainey KR; Alemayehu W; Welsh RC; Kumar A; King SB; Kirtane AJ
    J Am Heart Assoc; 2021 Jan; 10(1):e018104. PubMed ID: 33342230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges with Evidence-Based Management of Stable Ischemic Heart Disease.
    Patel AV; Bangalore S
    Curr Cardiol Rep; 2017 Feb; 19(2):11. PubMed ID: 28185167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.
    Iqbal J; Zhang YJ; Holmes DR; Morice MC; Mack MJ; Kappetein AP; Feldman T; Stahle E; Escaned J; Banning AP; Gunn JP; Colombo A; Steyerberg EW; Mohr FW; Serruys PW
    Circulation; 2015 Apr; 131(14):1269-77. PubMed ID: 25847979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetes on surgical versus percutaneous left main revascularization outcomes: a systematic review and meta-analysis.
    d'Entremont MA; Yagi R; Salia SJS; Zhang S; Shaban L; Bene-Alhasan Y; Papatheodorou S; Couture ÉL; Huynh T; Nguyen M; Hamaya R
    J Cardiothorac Surg; 2022 Apr; 17(1):61. PubMed ID: 35365159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials.
    Bertaina M; De Filippo O; Iannaccone M; Colombo A; Stone G; Serruys P; Mancone M; Omedè P; Conrotto F; Pennone M; Kimura T; Kawamoto H; Zoccai GB; Sheiban I; Templin C; Benedetto U; Cavalcante R; D'Amico M; Gaudino M; Moretti C; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):554-563. PubMed ID: 30095584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.